NeoGenomics Quarterly Balance Sheet
NASDAQ: NEOHealth CarePrecision InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NeoGenomics financial position
As of Jun 30, 2026, NeoGenomics reported total assets of $1.35 billion, down 3.0% from a year earlier against total liabilities of $566.5 million. Shareholders' equity stood at $785.7 million, or 58.1% of assets. The company held $145.5 million in cash and equivalents against $374.2 million of debt, a net debt position of $228.7 million.
The current ratio (current assets divided by current liabilities) was 3.60, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.48.
Summary generated from market data by MetaCap's automated system. Methodology
NeoGenomics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 145.54M | 146.14M | 159.62M | 164.12M | 154.72M | 346.19M | 367.01M | 361.99M | 355.08M | 331.91M | 342.49M | 306.24M |
| Receivables | 175.41M | 167.42M | 159.24M | 155.30M | 153.13M | 151.21M | 150.54M | 151.43M | 146.58M | 140.28M | 131.23M | 132.64M |
| Inventory | 27.14M | 29.84M | 28.57M | 28.46M | 34.17M | 29.77M | 26.75M | 24.46M | 23.21M | 20.32M | 24.16M | 24.05M |
| Total Current Assets | 381.48M | 373.68M | 376.29M | 382.46M | 392.55M | 573.93M | 596.02M | 590.24M | 584.20M | 573.90M | 596.81M | 586.95M |
| Property, Plant & Equipment | 80.94M | 83.66M | 84.83M | 85.47M | 85.46M | 89.60M | 94.10M | 93.04M | 92.16M | 87.86M | 92.01M | 94.52M |
| Goodwill | 524.00M | 524.00M | 524.34M | 524.34M | 524.14M | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M | 522.77M |
| Intangible Assets | 271.26M | 278.89M | 286.53M | 294.16M | 301.80M | 331.32M | 339.68M | 348.04M | 356.40M | 364.76M | 373.13M | 381.91M |
| Total Assets | 1.35B | 1.35B | 1.36B | 1.37B | 1.39B | 1.60B | 1.64B | 1.64B | 1.64B | 1.64B | 1.68B | 1.68B |
| Accounts Payable | 20.95M | 25.90M | 23.09M | 22.61M | 27.49M | 16.21M | 21.61M | 16.51M | 17.19M | 18.34M | 20.33M | 16.82M |
| Short-Term Debt | — | — | 0 | — | — | — | 200.78M | — | — | — | 0 | — |
| Total Current Liabilities | 105.88M | 84.59M | 88.30M | 97.87M | 100.12M | 279.69M | 301.24M | 296.41M | 289.96M | 76.71M | 96.30M | 92.93M |
| Long-Term Debt | 374.24M | — | 341.86M | — | — | — | 340.33M | — | — | — | 538.20M | — |
| Total Liabilities | 566.51M | 517.77M | 523.27M | 536.49M | 539.91M | 713.16M | 735.70M | 732.90M | 727.39M | 716.93M | 739.69M | 730.81M |
| Shareholders' Equity | 785.73M | 828.76M | 836.56M | 838.29M | 854.04M | 888.27M | 902.34M | 908.21M | 915.88M | 923.41M | 941.54M | 947.43M |
| Retained Earnings | -448.67M | -450.91M | -433.81M | -423.93M | -396.80M | -351.70M | -325.78M | -310.46M | -292.76M | -274.12M | -247.06M | -232.73M |
| Total Debt | 374.24M | — | 341.86M | — | — | — | 541.11M | — | — | — | 538.20M | — |
| Net Cash (Debt) | -228.70M | 146.14M | -182.24M | 164.12M | 154.72M | 346.19M | -174.10M | 361.99M | 355.08M | 331.91M | -195.71M | 306.24M |
| Shares Outstanding | 127.92M | 129.65M | 128.99M | 128.89M | 128.68M | 128.36M | 128.15M | 128.06M | 127.85M | 127.43M | 127.37M | 127.26M |
This table shows 12 quarterly periods of NeoGenomics's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow NEO's reporting calendar. What is a balance sheet?